Literature DB >> 12744982

An expanded role for functional neuroimaging in schizophrenia.

Joseph H Callicott1.   

Abstract

Functional magnetic resonance imaging is a surprisingly versatile tool in the quest for disentangling the complexities of mental illnesses such as schizophrenia. Yet, the identification of pathognomonic physiological features of the illness or even a consensus regarding the interpretation of reported findings remain unfulfilled goals, in spite of the increasing sophistication of this technology. Nonetheless, by providing quantification of brain function during various cognitive challenges, functional MRI has been used to leap ahead of these quandaries to identify relationships between genetic variation and brain function. By examining recent findings and efforts to link these findings to genes, this article will review these exciting developments in schizophrenia research.

Entities:  

Mesh:

Year:  2003        PMID: 12744982     DOI: 10.1016/s0959-4388(03)00041-2

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  7 in total

Review 1.  Approaches for adolescents with an affected family member with schizophrenia.

Authors:  Vaibhav A Diwadkar; Konasale M Prasad; Matcheri S Keshavan
Journal:  Curr Psychiatry Rep       Date:  2004-08       Impact factor: 5.285

2.  Dysregulation of the fibroblast growth factor system in major depression.

Authors:  S J Evans; P V Choudary; C R Neal; J Z Li; M P Vawter; H Tomita; J F Lopez; R C Thompson; F Meng; J D Stead; D M Walsh; R M Myers; W E Bunney; S J Watson; E G Jones; H Akil
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-13       Impact factor: 11.205

3.  Psychiatric Risk Gene Transcription Factor 4 Regulates Intrinsic Excitability of Prefrontal Neurons via Repression of SCN10a and KCNQ1.

Authors:  Matthew D Rannals; Gregory R Hamersky; Stephanie Cerceo Page; Morganne N Campbell; Aaron Briley; Ryan A Gallo; BaDoi N Phan; Thomas M Hyde; Joel E Kleinman; Joo Heon Shin; Andrew E Jaffe; Daniel R Weinberger; Brady J Maher
Journal:  Neuron       Date:  2016-03-10       Impact factor: 17.173

4.  Working memory and DLPFC inefficiency in schizophrenia: the FBIRN study.

Authors:  S G Potkin; J A Turner; G G Brown; G McCarthy; D N Greve; G H Glover; D S Manoach; A Belger; M Diaz; C G Wible; J M Ford; D H Mathalon; R Gollub; J Lauriello; D O'Leary; T G M van Erp; A W Toga; A Preda; K O Lim
Journal:  Schizophr Bull       Date:  2008-11-27       Impact factor: 9.306

5.  Smoking status as a potential confound in the BOLD response of patients with schizophrenia.

Authors:  Leonard Leyba; Andrew R Mayer; Randy L Gollub; Nancy C Andreasen; Vincent P Clark
Journal:  Schizophr Res       Date:  2008-08-05       Impact factor: 4.939

Review 6.  Intermediate phenotypes in schizophrenia: a selective review.

Authors:  Gilbert A Preston; Daniel R Weinberger
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

7.  Physiogenomic analysis of localized FMRI brain activity in schizophrenia.

Authors:  Andreas Windemuth; Vince D Calhoun; Godfrey D Pearlson; Mohan Kocherla; Kanchana Jagannathan; Gualberto Ruaño
Journal:  Ann Biomed Eng       Date:  2008-03-11       Impact factor: 3.934

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.